EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of Epstein Barr infection



Treatment of Epstein Barr infection



Official Gazette of the United States Patent & Trademark Office Patents 1237(4), Aug 22



A method of treating Epstein Barr virus infection in humans by administering a pharmaceutically effective amount of an antiviral agent selected from a group consisting of acyclovir, famciclovir, valacyclovir and a pharmaceutically acceptable salt thereof is provided.

(PDF 0-2 workdays service: $29.90)

Accession: 035980398

Download citation: RISBibTeXText



Related references

Production by epstein barr virus infection of an epstein barr nuclear antigen positive subline from an epstein barr nuclear antigen negative human lymphoma cell line without detectable epstein barr virus dna. International Journal of Cancer 16(1): 125-133, 1975

Infection of mouse lymphocytes by epstein barr virus 2 stimulation of cellular dna synthesis by epstein barr virus in the absence of epstein barr virus determined nuclear antigen induction and cell transformation. 1984

Establishment of epstein barr virus nuclear antigen expressing cell lines by infection of epstein barr virus genome negative human lymphoma cells with different epstein barr virus strains. International Journal Of Cancer: 161-166, 1976

An epstein barr virus genome negative cell line established from an american burkitts lymphoma receptor characteristics epstein barr virus infectibility and permanent conversion into epstein barr virus positive sublines by in vitro infection. Intervirology 5(6): 319-334, 1975

Cordycepin enhances Epstein-Barr virus lytic infection and Epstein-Barr virus-positive tumor treatment efficacy by doxorubicin. Cancer Letters 376(2): 240-248, 2016

Poly ploidization of epstein barr virus carrying lymphoma lines decreases the inducibility of epstein barr virus determined early antigen following p 3hr 1 virus super infection or iododeoxy uridine treatment. Intervirology 10(2): 94-101, 1978

Molecular size variation of epstein barr virus induced nuclear antigen is determined by the epstein barr viral genome studies on sublines of epstein barr virus negative lymphomas converted with different epstein barr virus substrains and on somatic hybrids. Intervirology 22(2): 85-96, 1984

Relationship between the amounts of epstein barr virus dna and epstein barr virus nuclear antigen per cell clonability and tumorigenicity in 2 epstein barr virus negative lymphoma lines and their epstein barr virus converted sublines. International Journal of Cancer 31(2): 163-170, 1983

Adoptive transfer of Epstein-Barr virus-specific T-lymphocytes in a patient with chronic active Epstein-Barr infection. DMW Deutsche Medizinische Wochenschrift 128(11): 548-550, 14 Maerz, 2003

Successful treatment of immediate allogeneic myeloablative hematopoietic stem cell transplantation from a HLA-mismatched sibling donor for active systemic epstein-barr virus-positive T-cell lymphoproliferative disease of childhood following primary acute epstein-barr virus infection. Clinical Case Reports 3(4): 231-236, 2015

Pathogenesis of epstein barr virus infection the host range of epstein barr now includes epithelial cells. Rapp, F (Ed ) Ucla (University Of California Los Angeles) Symposia on Molecular And Cellular Biology New Series, Vol 21 Herpesvirus; Meeting, Steamboat Springs, Colo , Usa, Apr 8-13, 1984 Xxiv+715p Alan R Liss, Inc : New York, N Y , Usa Illus 239-252, 1984, 1985

Adoptive transfer of Epstein-Barr virus-specific T-lymphocytes in chronic active Epstein-Barr infection. Deutsche Medizinische Wochenschrift 128(11): 548-550, 2003

Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans. American Journal of Pathology 145(4): 969-978, 1994

Epstein barr virus receptor implantation onto human b lymphocytes changes immuno globulin secretion patterns induced by epstein barr virus infection. European Journal of Immunology 12(1): 87-90, 1982

Infiltrations of Epstein-Barr virus-carrying cells in granular lymphocyte-proliferative disorders corresponding to chronic active Epstein-Barr virus infection. Pediatric Hematology and Oncology 19(7): 459-465, 2002